Xtide 50mg Injection


Product Info

Prescription required Yes
Marketer Biocon
Active Ingredient Oxaliplatin (50mg)
Storage Store below 30°C
Chemical ClassPlatinum Analogs
Habit FormingNo
Therapeutic ClassANTI NEOPLASTICS
Action ClassPlatinum compounds-Anticancer
User Rating4.1
User Reviews692

FAQ

Question
What if you forget to take Xtide Injection?
If you miss a dose of Xtide 50mg, please consult your doctor.
Answer

Xtide 50mg Injection Reviews

Xtide 50mg is used in the treatment of cancer of colon and rectum. It shows its working by stopping or slowing down the growth of cancer cells.

Xtide 50mg is given as an injection into vein by a qualified medical professional.  Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.

Nausea, fatigue, vomiting, and diarrhea are some common side effects of this medicine. This medicine may reduce the number of blood cells (decrease red blood and white blood cells) in your blood, thereby, increasing the susceptibility to infections. It may cause some serious allergic reaction, inform your doctor if you notice sore lips or mouth ulcers, rash, itching and difficulty breathing. Regular blood tests are required to check your blood cells along with heart, liver, and blood uric acid levels.

Before taking it, tell your doctor if you have heart disease, liver, or kidney problems or are taking any medicines to treat infections. Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. It makes men infertile, hence men should take doctor advice about the freezing of sperm before the treatment. You must avoid driving after taking this medicine as it may cause dizziness.

How Xtide 50mg Injection Works

Xtide 50mg is an anti-cancer medication. It works by damaging the genetic material (DNA and RNA) of the cancer cells which stops their growth and multiplication.

How to Use Xtide 50mg Injection

Your doctor or nurse will give you this medicine. Kindly do not self administer.

Uses of Xtide 50mg Injection

  • Cancer of colon and rectum

Xtide 50mg Injection Side Effects

Item form

Safety Tips

Alcohol  CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Xtide 50mg. Please consult your doctor.
Breast feeding  UNSAFE
Xtide 50mg is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Liver  CAUTION
Xtide 50mg should be used with caution in patients with liver disease. Dose adjustment of Xtide 50mg may be needed. Please consult your doctor.
Pregnancy  CONSULT YOUR DOCTOR
Xtide 50mg is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
Driving  UNSAFE
Xtide 50mg may cause side effects which could affect your ability to drive.Xtide 50mg treatment may result in an increased risk of dizziness, nausea, and vomiting, and other neurological symptoms that affect walking and this may affect your ability to drive.
Kidney  CAUTION
Xtide 50mg should be used with caution in patients with severe kidney disease. Dose adjustment of Xtide 50mg may be needed. Please consult your doctor.Limited information is available on the use of Xtide 50mg in these patients. No dose adjustment is recommended in patients with mild to moderate kidney disease.

Quick Tips

  • Xtide 50mg is given as an injection into veins under the supervision of a doctor.
  • Xtide 50mg is given as an injection into veins under the supervision of a doctor.

References

  1. Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 1034-35.
  2. Oxaliplatin. Bridgewater, New Jersey: sanofi-aventis U.S; 2002 [revised Oct. 2015].
  3. Chabner BA, Bertino J, Cleary J, et al. Cytotoxic Agents. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 1689-90.
  4. Central Drugs Standard Control Organisation (CDSCO).
  5. Oxaliplatin. Hayes, UK: Ranbaxy (UK) Limited a Sun Pharmaceutical Company; 2011 [19 Apr. 2018].
  6. Chu E, Sartorelli AC. Cancer Chemotherapy. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. pp. 944.

Other Medical Preparations